National Multicenter Cohort Registry Study of Rapid rEcurrences of Coronary Unexplained In-stent Restenosis

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

1000 participants

Study Classification

OBSERVATIONAL

Study Start Date

2020-06-03

Study Completion Date

2035-04-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This project aims to establish a clinical cohort and diagnostic assessment framework by conducting a national multicenter cohort registry study. Through the collection of patients' clinical characteristics, it will achieve the registration, management, follow-up, and analysis of patients with Rapid rEcurrences of Coronary Unexplained in-stent Restenosis (RECUR).

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

The Prognosis of Patients After PCI：a Multi-center Study in China

NCT05614050

Inflammation

RECRUITING

Precision Therapy in Complex High-risk Coronary Artery Disease

NCT04444960

Coronary Artery Disease

UNKNOWN

Intravascular Imaging Evaluated Calcified Nodule China Registry

NCT07262359

Coronary Artery Disease Coronary Artery Atherosclerosis Coronary Calcified Nodules +1 more

NOT_YET_RECRUITING

Beijing Percutaneous Coronary Intervention Registry

NCT01417325

Coronary Heart Disease

UNKNOWN

Functional ComprEhensive AssessmenT by IVUS Reconstruction in Patients With Suspected IschEmic Heart Disease (FEATURE)

NCT05694065

Ischemic Heart Disease

ACTIVE_NOT_RECRUITING

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Coronary Artery Disease Arteritis In-Stent Stenosis (Restenosis) of Coronary Artery Stent

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Rapid rEcurrences of Coronary Unexplained in-stent Restenosis (RECUR)

Treatment made by experienced clinicians

Intervention Type OTHER

Treatment made by experienced clinicians

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Treatment made by experienced clinicians

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Age ≥ 18 years;
2. Patients meeting the diagnostic criteria for Rapid rEcurrences of Coronary Unexplained in-stent Restenosis (RECUR);
3. Patients fully informed about the trial procedures who provide written informed consent.

Exclusion Criteria

1. Patients presenting with any of the following:

* Other severe comorbidities (e.g., malignant tumors, heart failure) with a life expectancy \<12 months;

* Known autoimmune/rheumatic diseases including systemic lupus erythematosus, Takayasu arteritis, Behçet's disease, polyarteritis nodosa, Wegener granulomatosis (granulomatosis with polyangiitis), eosinophilic arteritis, giant cell arteritis, rheumatoid arthritis, or IgG4-related disease;

* Variant angina (Prinzmetal's angina);

* Coronary artery dissection;

* Thrombophilia;

* Stent underexpansion.
2. Presence of psychiatric disorders;
3. Known inability to complete expected study follow-up for any reason;
4. Patients deemed ineligible for enrollment by the investigator.

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No